Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 1/2015

01.01.2015 | Otology

Effect of caffeic acid phenethyl ester on myringosclerosis development in the tympanic membrane of rat

verfasst von: Vefa Kinis, Musa Ozbay, Ulas Alabalik, Aylin Gul, Beyhan Yilmaz, Fazi Emre Ozkurt, Engin Sengul, Ismail Topcu

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Myringosclerosis is hyalinization and calcification of certain areas of the tympanic membrane, especially the fibrous lamina propria layer and appears as white sclerotic lesions. Ventilation tube insertion is one of the most performed operations in the pediatric otorhinolaryngology practice to treat chronic otitis media with effusion. Myringosclerosis is a very common sequela of ventilation tube insertion. In this experimental study, our aim was to show the histopathological effects of caffeic acid phenethyl ester on myringosclerosis development in rat tympanic membrane after myringotomy. The rats were randomly categorized into four experimental groups including the comparison group (n = 4), non-treated group (n = 7), the saline (control) group (n = 7), the caffeic acid phenethyl ester group (n = 7). Non-treated group did not receive any treatment for 15 days. Saline (2.5 mL/kg, intraperitoneal) was administered to the third group once a day for 15 days. Fourth group received caffeic acid phenethyl ester intraperitoneally once a day at a dose of 10 μmol/kg for 15 days. Myringotomy was performed on the right tympanic membrane of all rats except comparison group using a sterile pick with the help of an operating microscope. Histopathological examination of myringosclerosis formation was done by a pathologist under light microscope. In histopathological analysis of groups, the severity of inflammation was milder in caffeic acid phenethyl ester group compared to non-treated and saline groups (p < 0.05). There was less myringosclerotic plaques in caffeic acid phenethyl ester group than in non-treated and saline groups (p < 0.05). TM thickness measurements were very close to each other in non-treated and saline groups. The tympanic membrane thickness of caffeic acid phenethyl ester group was much thinner than the other two groups (p < 0.05). Caffeic acid phenethyl ester decreases inflammation severity and the formation of myringosclerotic plaques. These two effects resulted in thinner tympanic membranes of rats which were treated with caffeic acid phenethyl ester. As a result, caffeic acid phenethyl ester has potential preventive effects on myringosclerosis development after myringotomy and ventilation tube insertion.
Literatur
1.
Zurück zum Zitat Albiin N, Hellström S, Salen B, Stenfors LE, Söderberg O (1983) The anatomy of the eustachian tube in the rat: a macro-and microscopical study. Anat Rec 207:513–521PubMedCrossRef Albiin N, Hellström S, Salen B, Stenfors LE, Söderberg O (1983) The anatomy of the eustachian tube in the rat: a macro-and microscopical study. Anat Rec 207:513–521PubMedCrossRef
2.
Zurück zum Zitat Mattsson C, Marklund SL, Hellström S (1997) Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol 106:513–518PubMedCrossRef Mattsson C, Marklund SL, Hellström S (1997) Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol 106:513–518PubMedCrossRef
3.
Zurück zum Zitat Mattsson C, Stierna P, Hellstrom S (2000) Treatment with dexamethasone arrests the development of myringosclerosis after myringotomy. Am J Otol 21:804–808PubMed Mattsson C, Stierna P, Hellstrom S (2000) Treatment with dexamethasone arrests the development of myringosclerosis after myringotomy. Am J Otol 21:804–808PubMed
4.
Zurück zum Zitat Özcan C, Görür K, Cinel L, Talas DU, Unal M, Cinel I (2002) The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Pediatr Otorhinolaryngol 63:179–184PubMedCrossRef Özcan C, Görür K, Cinel L, Talas DU, Unal M, Cinel I (2002) The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Pediatr Otorhinolaryngol 63:179–184PubMedCrossRef
5.
Zurück zum Zitat Tos M, Bonding P, Paulsen G (1983) Tympanosclerosis of the drum in secretory otitis media after insertion of grommets: a prospective, comparative study. J Laryngol Otol 97:489–496PubMedCrossRef Tos M, Bonding P, Paulsen G (1983) Tympanosclerosis of the drum in secretory otitis media after insertion of grommets: a prospective, comparative study. J Laryngol Otol 97:489–496PubMedCrossRef
6.
Zurück zum Zitat Mattsson C, Magnuson K, Hellström S (1995) An increased oxygen concentration causes myringosclerosis in traumatized tympanic membranes. Experimental study. Ann Otol Rhinol Laryngol 104:625–632PubMedCrossRef Mattsson C, Magnuson K, Hellström S (1995) An increased oxygen concentration causes myringosclerosis in traumatized tympanic membranes. Experimental study. Ann Otol Rhinol Laryngol 104:625–632PubMedCrossRef
7.
Zurück zum Zitat Uneri C, Sari M, Akboğa J, Yüksel M (2006) Vitamin E-coated tympanostomy tube insertion decreases the quantity of free radicals in tympanic membrane. Laryngoscope 116:140–143PubMedCrossRef Uneri C, Sari M, Akboğa J, Yüksel M (2006) Vitamin E-coated tympanostomy tube insertion decreases the quantity of free radicals in tympanic membrane. Laryngoscope 116:140–143PubMedCrossRef
8.
Zurück zum Zitat Mattsson C, Hellström S (1997) Inhibition of the development of myringosclerosis by local administration of fenspiride, an anti-inflammatory drug. Eur Arch Otorhinolaryngol 254:425–429PubMedCrossRef Mattsson C, Hellström S (1997) Inhibition of the development of myringosclerosis by local administration of fenspiride, an anti-inflammatory drug. Eur Arch Otorhinolaryngol 254:425–429PubMedCrossRef
9.
Zurück zum Zitat Asiri S, Hasham A, al Anazy F, Zakzouk S, Banyar A (1999) Tympanosclerosis: review of literature and incidence among patients with middle-ear infection. J Laryngol Otol 113:1076–1080PubMedCrossRef Asiri S, Hasham A, al Anazy F, Zakzouk S, Banyar A (1999) Tympanosclerosis: review of literature and incidence among patients with middle-ear infection. J Laryngol Otol 113:1076–1080PubMedCrossRef
10.
Zurück zum Zitat Paparella MM, Schachern P (1994) New developments in treating otitis media. Ann Otol Rhinol Laryngol Suppl 163:7–10PubMed Paparella MM, Schachern P (1994) New developments in treating otitis media. Ann Otol Rhinol Laryngol Suppl 163:7–10PubMed
11.
Zurück zum Zitat Liao HF, Chen YY, Liu JJ, Hsu ML, Shieh HJ, Liao HJ, Shieh CJ, Shiao MS, Chen YJ (2003) Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agric Food Chem 51:7907–7912PubMedCrossRef Liao HF, Chen YY, Liu JJ, Hsu ML, Shieh HJ, Liao HJ, Shieh CJ, Shiao MS, Chen YJ (2003) Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agric Food Chem 51:7907–7912PubMedCrossRef
12.
Zurück zum Zitat Gokalp O, Uz E, Cicek E, Yilmaz HR, Ozer MK, Altunbas A, Ozcelik N (2006) Ameliorating role of caffeic acid phenethyl ester (CAPE) against isoniazid-induced oxidative damage in red blood cells. Mol Cell Biochem 290:55–59PubMedCrossRef Gokalp O, Uz E, Cicek E, Yilmaz HR, Ozer MK, Altunbas A, Ozcelik N (2006) Ameliorating role of caffeic acid phenethyl ester (CAPE) against isoniazid-induced oxidative damage in red blood cells. Mol Cell Biochem 290:55–59PubMedCrossRef
13.
Zurück zum Zitat Sud’ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD (1993) Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 329:21–24PubMedCrossRef Sud’ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD (1993) Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 329:21–24PubMedCrossRef
14.
Zurück zum Zitat Institute of Laboratory Animal Research. Commission on Life Sciences. National Research Council (1996) The guide for the care and use of laboratory animals, 7th edn. National Academy of Sciences, Washington, DC Institute of Laboratory Animal Research. Commission on Life Sciences. National Research Council (1996) The guide for the care and use of laboratory animals, 7th edn. National Academy of Sciences, Washington, DC
15.
Zurück zum Zitat Banerjee T, Kuypers FA (2004) Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol 124:392–402CrossRef Banerjee T, Kuypers FA (2004) Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol 124:392–402CrossRef
16.
Zurück zum Zitat Bhaya MH, Schachern PA, Morizono T, Paparella MM (1993) Pathogenesis of tympanosclerosis. Otolaryngol Head Neck Surg 109:413–420PubMed Bhaya MH, Schachern PA, Morizono T, Paparella MM (1993) Pathogenesis of tympanosclerosis. Otolaryngol Head Neck Surg 109:413–420PubMed
17.
Zurück zum Zitat Spratley JE, Hellström SO, Mattsson CK, Pais-Clemente M (2001) Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in rat. Ann Otol Rhinol Laryngol 110:585–591PubMedCrossRef Spratley JE, Hellström SO, Mattsson CK, Pais-Clemente M (2001) Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in rat. Ann Otol Rhinol Laryngol 110:585–591PubMedCrossRef
18.
Zurück zum Zitat Song JJ, Kwon SK, Cho CG, Park SW (2007) The effect of caffeic acid phenethyl ester on the prevention of experimentally induced myringosclerosis. Int J Pediatr Otorhinolaryngol 71:1287–1291PubMedCrossRef Song JJ, Kwon SK, Cho CG, Park SW (2007) The effect of caffeic acid phenethyl ester on the prevention of experimentally induced myringosclerosis. Int J Pediatr Otorhinolaryngol 71:1287–1291PubMedCrossRef
19.
Zurück zum Zitat Dawes PJ, Bingham BJ, Ryhs R, Griffiths MV (1991) Aspirating middle ear effusions when inserting ventilation tubes: does it influence post-operative otorrhoea, tube obstruction or the development of tympanosclerosis? Clin Otolaryngol Allied Sci 16:457–461PubMedCrossRef Dawes PJ, Bingham BJ, Ryhs R, Griffiths MV (1991) Aspirating middle ear effusions when inserting ventilation tubes: does it influence post-operative otorrhoea, tube obstruction or the development of tympanosclerosis? Clin Otolaryngol Allied Sci 16:457–461PubMedCrossRef
20.
21.
Zurück zum Zitat Sade J, Luntz M (1993) Dynamic measurements of gas composition in the middle ear II: steady state value. Acta Otolaryngol 113:353–357PubMedCrossRef Sade J, Luntz M (1993) Dynamic measurements of gas composition in the middle ear II: steady state value. Acta Otolaryngol 113:353–357PubMedCrossRef
22.
Zurück zum Zitat Felding JU, Rasmussen JB, Lildholdt T (1987) Gas composition of the normal and the ventilated middle ear cavity. Scand J Clin Lab Invest Suppl 186:31–41PubMedCrossRef Felding JU, Rasmussen JB, Lildholdt T (1987) Gas composition of the normal and the ventilated middle ear cavity. Scand J Clin Lab Invest Suppl 186:31–41PubMedCrossRef
23.
Zurück zum Zitat Mattsson C, Carlsson L, Marklund SL, Hellström S (1997) Myringotomized mice develop myringosclerosis in the pars flaccida and not in the pars tensa. Laryngoscope 107:200–205PubMedCrossRef Mattsson C, Carlsson L, Marklund SL, Hellström S (1997) Myringotomized mice develop myringosclerosis in the pars flaccida and not in the pars tensa. Laryngoscope 107:200–205PubMedCrossRef
24.
Zurück zum Zitat Fadillioglu E, Oztas E, Erdogan H, Yagmurca M, Sogut S, Ucar M, Irmak MK (2004) Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol 24:47–52PubMedCrossRef Fadillioglu E, Oztas E, Erdogan H, Yagmurca M, Sogut S, Ucar M, Irmak MK (2004) Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol 24:47–52PubMedCrossRef
25.
Zurück zum Zitat Bakır S, Özbay M, Gün R, Yorgancılar E, Kınış V, Keleş A, Abakay A, Gökalp O, Topçu İ (2013) The protective role of caffeic acid phenethyl ester against streptomycin ototoxicity. Am J Otolaryngol 34:16–21PubMedCrossRef Bakır S, Özbay M, Gün R, Yorgancılar E, Kınış V, Keleş A, Abakay A, Gökalp O, Topçu İ (2013) The protective role of caffeic acid phenethyl ester against streptomycin ototoxicity. Am J Otolaryngol 34:16–21PubMedCrossRef
26.
Zurück zum Zitat Irmak MK, Fadillioglu E, Sogut S, Erdogan H, Gulec M, Ozer M, Yagmurca M, Gozukara ME (2003) Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain. Cell Biochem Funct 21:283–289PubMedCrossRef Irmak MK, Fadillioglu E, Sogut S, Erdogan H, Gulec M, Ozer M, Yagmurca M, Gozukara ME (2003) Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain. Cell Biochem Funct 21:283–289PubMedCrossRef
27.
Zurück zum Zitat Kazikdas KC, Uguz MZ, Erbil G, Tugyan K, Yilmaz O, Guneli E, Altun Z (2006) The antioxidant effect of alpha-tocopherol in the prevention of experimentally induced myringosclerosis. Otol Neurotol 27:882–886PubMedCrossRef Kazikdas KC, Uguz MZ, Erbil G, Tugyan K, Yilmaz O, Guneli E, Altun Z (2006) The antioxidant effect of alpha-tocopherol in the prevention of experimentally induced myringosclerosis. Otol Neurotol 27:882–886PubMedCrossRef
28.
Zurück zum Zitat Akbaş Y, Pata YS, Görür K, Polat G, Polat A, Ozcan C, Unal M (2003) Hear Res. The effect of l-carnitine on the prevention of experimentally induced myringosclerosis in rats. Hear Res 184:107–112PubMedCrossRef Akbaş Y, Pata YS, Görür K, Polat G, Polat A, Ozcan C, Unal M (2003) Hear Res. The effect of l-carnitine on the prevention of experimentally induced myringosclerosis in rats. Hear Res 184:107–112PubMedCrossRef
29.
Zurück zum Zitat Dogan E, Erdag TK, Sarioglu S, Ecevit MC, Ikiz AO, Güneri EA (2011) The preventive effect of N-nitro l-arginine methyl ester in experimentally induced myringosclerosis. Int J Pediatr Otorhinolaryngol 75:1035–1039PubMedCrossRef Dogan E, Erdag TK, Sarioglu S, Ecevit MC, Ikiz AO, Güneri EA (2011) The preventive effect of N-nitro l-arginine methyl ester in experimentally induced myringosclerosis. Int J Pediatr Otorhinolaryngol 75:1035–1039PubMedCrossRef
30.
Zurück zum Zitat Emir H, Kaptan ZK, Samim E, Sungu N, Ceylan K, Ustun H (2009) The preventive effect of ginkgo biloba extract in myringosclerosis: study in rats. Otolaryngol Head Neck Surg 140:171–176PubMedCrossRef Emir H, Kaptan ZK, Samim E, Sungu N, Ceylan K, Ustun H (2009) The preventive effect of ginkgo biloba extract in myringosclerosis: study in rats. Otolaryngol Head Neck Surg 140:171–176PubMedCrossRef
Metadaten
Titel
Effect of caffeic acid phenethyl ester on myringosclerosis development in the tympanic membrane of rat
verfasst von
Vefa Kinis
Musa Ozbay
Ulas Alabalik
Aylin Gul
Beyhan Yilmaz
Fazi Emre Ozkurt
Engin Sengul
Ismail Topcu
Publikationsdatum
01.01.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 1/2015
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-013-2832-2

Weitere Artikel der Ausgabe 1/2015

European Archives of Oto-Rhino-Laryngology 1/2015 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

HNO-Op. auch mit über 90?

16.04.2024 HNO-Chirurgie Nachrichten

Mit Blick auf das Risiko für Komplikationen nach elektiven Eingriffen im HNO-Bereich scheint das Alter der Patienten kein ausschlaggebender Faktor zu sein. Entscheidend ist offenbar, wie fit die Betroffenen tatsächlich sind.

Intrakapsuläre Tonsillektomie gewinnt an Boden

16.04.2024 Tonsillektomie Nachrichten

Gegenüber der vollständigen Entfernung der Gaumenmandeln hat die intrakapsuläre Tonsillektomie einige Vorteile, wie HNO-Fachleute aus den USA hervorheben. Sie haben die aktuelle Literatur zu dem Verfahren gesichtet.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.